Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Provenge
Provenge
Where Is Biotechnology's Next 'Anti-PD-1'?
Seeking Alpha
Tue, 06/18/13 - 09:50 am
anti-PD-1 immunotherapy
Dendreon
Merck
Bristol-Myers Squibb
Baxter International
Yervoy
Provenge
lambrolizumab
MPDL3208A
Bracing For Dendreon Q1 2013 Earnings - All Eyes On Provenge
Seeking Alpha
Wed, 05/8/13 - 09:25 am
Dendreon
earnings
Provenge
Understanding Why Cancer Vaccines Fail
Motley Fool
Mon, 04/1/13 - 10:46 am
cancer
vaccines
Dendreon
Provenge
Bristol-Myers Squibb
Yervoy
Sanofi
TheraCys
Will Dendreon Continue to Plummet?
Wall St. Cheat Sheet
Tue, 03/26/13 - 10:38 am
Dendreon
Provenge
Is This Cancer Drug Really a Vaccine?
Motley Fool
Sat, 03/9/13 - 12:31 pm
Dendreon
cancer vaccines
vaccines
Provenge
Dendreon Jump-Starts Its New Direct-To-Consumer Ad Campaign
Seeking Alpha
Fri, 03/8/13 - 10:08 am
Dendreon
Provenge
DTC
drug ads
Tackling Cancer: Prostate Cancer's Biggest Current and Upcoming Players
Motley Fool
Wed, 03/6/13 - 09:49 am
prostate cancer
Zytiga
JNJ
Xtandi
Medivation
Astellas
Provenge
Dendreon
Jevtana
Sanofi
Will Cost Cutting Offset Competitive Pressures For This Biotech In 2013?
Motley Fool
Thu, 02/7/13 - 10:22 am
Dendreon
Provenge
Dendreon Just Raised the Bar
Motley Fool
Fri, 01/18/13 - 09:16 am
Dendreon
Provenge
[video]Dendreon: 3 Areas You Must Watch
Motley Fool
Mon, 01/14/13 - 11:59 am
Dendreon
Provenge
Dendreon Rises on Optimism Over Cancer Drug Provenge
Bloomberg
Fri, 01/11/13 - 12:05 pm
Dendreon
prostate cancer
Provenge
Vivus, Dendreon Set To Rally From The January Effect
Seeking Alpha
Wed, 12/19/12 - 01:35 pm
Dendreon
Vivus
Provenge
Qsymia
RNA Technology Could Save Lives, Create Investment Opportunity
Motley Fool
Sat, 12/15/12 - 12:33 pm
JNJ
Zytiga
Dendreon
Provenge
Dendreon Dodges A Bullet
Seeking Alpha
Tue, 12/11/12 - 10:18 am
JNJ
Dendreon
Zytiga
prostate cancer
Provenge
10 top drug launch disasters
Fierce Pharma
Wed, 11/28/12 - 11:13 am
drug launches
Rare Disease Therapeutics
Anascorp
AstraZeneca
Brilinta
Somaxon
Silenor
Sanofi
Multaq
Savient
Krystexxa
XenoPort
Horizant
Human Genome Sciences
Benlysta
Zaltrap
Dendreon
Provenge
KV Pharmaceutical
Makena
Prostate Cancer Market Takes Shape - Part 1: Dendreon And Medivation
Seeking Alpha
Wed, 11/14/12 - 10:33 am
prostate cancer
Medivation
Dendreon
Provenge
JNJ
Sanofi
Dendreon: What's The Company Worth Per Share?
Seeking Alpha
Fri, 11/2/12 - 11:01 am
Dendreon
Provenge
JNJ
Will Dendreon Surprise The Street On October 30?
Seeking Alpha
Mon, 10/22/12 - 11:52 am
Dendreon
Provenge
Dendreon and Celgene Cancer Treatment Catalysts Face Rocky Road
Wall St. Cheat Sheet
Mon, 10/15/12 - 11:41 am
Celgene
Dendron
Provenge
prostate cancer
Dendreon's Provenge: Early Stage Use
Seeking Alpha
Mon, 08/20/12 - 10:51 am
Provenge
prostate cancer
Dendreon
JNJ
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »